Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Orphanet Journal of Rare Diseases
Published in: Orphanet Journal of Rare Diseases 1/2015

Open Access 01-12-2015 | Erratum

Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union

Authors: Stelios Tsigkos, Segundo Mariz, Jordi Llinares, Laura Fregonese, Stiina Aarum, Frauke Naumann-Winter, Kerstin Westermark, Bruno Sepodes

Published in: Orphanet Journal of Rare Diseases | Issue 1/2015

Login to get access

Excerpt

After publication of [1] it came to the authors’ attention that Frauke Naumann-Winter’s name was displayed incorrectly. The correct spelling of their name is included in this erratum. …
Literature
1.
Tsigkos S, Mariz S, Llinares J, Fregonese L, Aarum S, Frauke N, et al. Establishing medical plausibility in the context of orphan medicines designation in the European Union. Orphanet Journal of Rare Diseases. 2014; 9:175.PubMedCentralCrossRefPubMed
Metadata
Title
Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union
Authors
Stelios Tsigkos
Segundo Mariz
Jordi Llinares
Laura Fregonese
Stiina Aarum
Frauke Naumann-Winter
Kerstin Westermark
Bruno Sepodes
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2015
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-015-0309-7

Other articles of this Issue 1/2015

Orphanet Journal of Rare Diseases 1/2015 Go to the issue

Research

Natural disease history and characterisation of SUMF1 molecular defects in ten unrelated patients with multiple sulfatase deficiency

Research

Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C

Erratum

Erratum to: Expression profiling of white sponge nevus by RNA sequencing revealed pathological pathways

Letter to the Editor

A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment

Research

No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome

Research

Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations